FDA Panel Backs Limiting Use Of Testosterone
The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against using testosterone therapy in healthy girls. Although the FDA approved testosterone therapy for the treatment of diseases involving the testes, pituitary and hypothalamus, it hasn't been approved for treating age-associated declines in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the security of testosterone. The study included about 800 elderly men with low testosterone and symptoms associated with this ailment, like http://tinyurl.com/zq3zb78 physical and sexual dysfunction. Since the men's heart health was monitored, the research is expected to shed more light on the safety of testosterone treatment.
The recent contradictory findings on testosterone therapy prompted his team to conduct a large systematic literature search for studies evaluating the relationship between testosterone replacement therapy and cardiovascular events among guys and Patel. An estimated 13 million men in America suffer with low testosterone, which happens when the body does not make enough hormones as a result of a problem with the testicles or pituitary gland. This clarifies obvious aging, an individual's sudden weight gain and loss of energy.
And many women have a knee-jerk suspicion that any hormone treatment can raise their risk of breast cancer. However, clinical studies show that testosterone not only does not increase a woman's risk of breast cancer , it may play a key role in warding off the disease. Glaser believes this will likely stay the status quo for a while, given the prohibitive cost of running the long term safety studies needed to acquire FDA approval that is more total.
URL del sito web: http://tinyurl.com/zq3zb78